Inventor
CZECH JOERG
DE28 patents
⚠️ This page may combine multiple inventors who share the name “CZECH JOERG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOECHST AG
7 patentsUS6146658ANov 14, 2000
Prodrugs, their preparation and use as pharmaceuticals
HOECHST AG48 citations95
US5284856AFeb 8, 1994
Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
HOECHST AG87 citations94
US5935995AAug 10, 1999
Prodrugs for the therapy of tumors and inflammatory disorders
HOECHST AG33 citations91
US6020315AFeb 1, 2000
Preparation having increased in vivo tolerability
HOECHST AG35 citations90
US5886033AMar 23, 1999
Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders
HOECHST AG11 citations71
US6020372AFeb 1, 2000
Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders
HOECHST AG4 citations60
US5817800AOct 6, 1998
Inhibitors of β-glucuronidase and their use in the treatment of carcinamatosis and inflammation
HOECHST AG3 citations60
BEHRINGWERKE AG
6 patentsUS5621002AApr 15, 1997
Prodrugs for enzyme mediated activation
BEHRINGWERKE AG217 citations97
US5710134AJan 20, 1998
Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders
BEHRINGWERKE AG54 citations96
US5955100ASep 21, 1999
Prodrugs their preparation and use as pharmaceuticals
BEHRINGWERKE AG75 citations95
US7060495B2Jun 13, 2006
Fusion proteins for prodrug activation
BEHRINGWERKE AG30 citations92
US5877158AMar 2, 1999
Pro-prodrugs, their production and use
BEHRINGWERKE AG45 citations92
US5519018AMay 21, 1996
Substituted phenols and their use for the treatment of disorders caused by cell proliferation
BEHRINGWERKE AG29 citations89
AVENTIS PHARMA GMBH
3 patentsUS6602688B1Aug 5, 2003
Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coli
AVENTIS PHARMA GMBH43 citations94
US6610299B1Aug 26, 2003
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
AVENTIS PHARMA GMBH14 citations84
US6475486B1Nov 5, 2002
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
AVENTIS PHARMA GMBH13 citations73
SANOFI AVENTIS DEUTSCHLAND
3 patentsUS7364887B2Apr 29, 2008
Use of PAK inhibitor for the treatment of a joint disease
SANOFI AVENTIS DEUTSCHLAND3 citations57
US7314753B2Jan 1, 2008
Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coli
SANOFI AVENTIS DEUTSCHLAND0 citations50
US7892744B2Feb 22, 2011
Analysis and use of PAR1 polymorphisms for evaluating the risk of cardiovascular disorders
SANOFI AVENTIS DEUTSCHLAND0 citations49